Nasze metody

Our methods


Methods based on the input information and the final effect and searching for relationships between them (regression and classification methods such as linear and logistic regression, support vector machines, decision trees, Bayesian classifiers, multilayer neural networks, and image analysis).


Methods using only input information (without the final effect), searching for relationships, similarities, and differences between the analyzed objects (e.g., cluster analysis, neural networks, self-organizing maps, principal component analysis, extraction-maximization algorithms).


It allows you to select the best compounds for further in vitro and in vivo testing. The methods used allow both the design of compounds based on the receptor structure (SBDD – structure-based drug design) and the design of compounds based on the structure of the ligand (LBDD – ligand-based drug design).


Quantitative Structure-Activity Relationship
A method that expresses the relationship between chemical structure and properties in a quantitative way. Using information encoded in numbers about a given chemical structure and its toxic effect, a mathematical model can be created, capable of predicting in silico physicochemical properties, biological activity, and ADMET—adsorption properties, distribution, metabolism, excretion, and toxicity of experimentally untested compounds.


Clustering and read-across assessment methods
A compound similarity approach. According to the guidelines related to the REACH Regulation, one group/category includes substances with similar physicochemical, toxicological, and ecotoxicological properties and chemical structures. Thanks to these relationships, it is possible to predict the properties of the target substance using data available for the source compounds. In this way, it is possible to obtain knowledge about new, untested substances only based on their properties and chemical structure.


Weight of Evidence
The ‘weight of evidence’ procedure refers to collecting, weighing, and evaluating evidence to draw conclusions about a substance’s potential toxic effects. In this process, selected studies are qualified regarding qualitative acceptability criteria, compliance with current OECD and other guidelines, GLP status, etc. A weight-of-evidence approach can be performed to assess virtually any in vitro and in vivo toxicity indicator.

Want to know more?